EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
09/10/2025
Voltar para busca
Dado oficial do USPTO
GAMIDA CELL ASSIST
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
GAMIDA CELL ASSIST
ST13
US500000088607016Classe
35, 36, 44
Pedido
88607016
Registro
7108148
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
59
Atualização mais recente
15/10/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 36, 44
Data de depósito
06/09/2019
Data de registro
11/07/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
11/07/2023
Última transação
15/10/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
19/04/2023
Primeiro uso no comércio
19/04/2023
Código do desenho
4
Tipo de titular
03
Localização do titular
NAPLES, FL
Examinador
PARK,JENNY K
Unidade examinadora
L40
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
GAMIDA CELL INC.
GAMIDA CELL LTD.
GAMIDA CELL INC.
Representantes
Mark A. Jansen Fenwick & West LLP
Classificação técnica
Classes Nice
Classe 35Classe 36Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Promoting public awareness of issues related to the testingdiagnosistreatment and patient outcome in the fields of pharmaceuticalscell therapieshematologyleukemiaoncologyblood and bone marrow diseases and disorders; promoting the interests of patients with cancerblood and bone marrow diseases and disordersby means of public advocacy
Classe 36
Providing information regarding insurance coverage and reimbursement for prescription drugs; administration of a patient assistance program for providing prescription drugs at reduced cost
Classe 44
Providing educational medical information in the fields of in the fields of pharmaceuticalscell therapieshematologyleukemiaoncologyblood and bone marrow diseases and disordersincluding the testingdiagnosistreatment and patient outcomes related thereto; Medical servicesproviding educational information regarding prescription drugs and disease treatment; providing a call center for responding to patient and caregiver inquiries and providing educational guidance in the field of prescription pharmaceuticals and disease treatment
Publicações
Histórico de despachos e eventos da marca no USPTO.
59 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/10/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/10/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/10/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/10/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/10/2025
WOAG
WITHDRAWAL OF ATTORNEY GRANTED
10/09/2025
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
10/09/2025
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
21/05/2025
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
27/03/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/07/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
11/07/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
08/06/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/06/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/05/2023
IUAF
USE AMENDMENT FILED
28/04/2023
EISU
TEAS STATEMENT OF USE RECEIVED
28/04/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/10/2022
EX5G
SOU EXTENSION 5 GRANTED
05/10/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/10/2022
EXT5
SOU EXTENSION 5 FILED
21/09/2022
EEXT
SOU TEAS EXTENSION RECEIVED
21/09/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
22/04/2022
EX4G
SOU EXTENSION 4 GRANTED
20/04/2022
EXT4
SOU EXTENSION 4 FILED
20/04/2022
EEXT
SOU TEAS EXTENSION RECEIVED
20/04/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
15/02/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
15/02/2022
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
15/02/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
15/02/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
15/02/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
15/02/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
30/10/2021
EX3G
SOU EXTENSION 3 GRANTED
28/10/2021
EXT3
SOU EXTENSION 3 FILED
28/10/2021
EEXT
SOU TEAS EXTENSION RECEIVED
28/10/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/04/2021
EX2G
SOU EXTENSION 2 GRANTED
08/04/2021
EXT2
SOU EXTENSION 2 FILED
08/04/2021
EEXT
SOU TEAS EXTENSION RECEIVED
08/04/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/10/2020
EX1G
SOU EXTENSION 1 GRANTED
01/10/2020
EXT1
SOU EXTENSION 1 FILED
01/10/2020
EEXT
SOU TEAS EXTENSION RECEIVED
01/10/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
28/04/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/03/2020
PUBO
PUBLISHED FOR OPPOSITION
03/03/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/02/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
29/01/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/01/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/01/2020
ALIE
ASSIGNED TO LIE
28/01/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
21/01/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
16/12/2019
GNRT
NON-FINAL ACTION E-MAILED
16/12/2019
CNRT
NON-FINAL ACTION WRITTEN
16/12/2019
DOCK
ASSIGNED TO EXAMINER
09/12/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
17/09/2019
NWAP
NEW APPLICATION ENTERED
10/09/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace GAMIDA CELL ASSIST ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.